Addressing the Burden of CardioVascular Disease in Asia at the Cardiovascular Clinical Trialist Asia Forum 2014
The CardioVascular Clinical Trialists Asia Forum (CVCT Asia Forum 2014) will be held from the 4 – 6 July 2014 at the Fullerton Hotel, Singapore. The forum is endorsed by the Asia-Pacific Society of Cardiology and the Singapore Cardiac Society. The National University Heart Centre Singapore, Quintiles Real-World & Late Phase Research, Singapore Clinical Research Institute, European Society of Cardiology Working Group on Cardiovascular Pharmacology and Drug Therapy and the Singapore Exhibition & Convention Bureau have also lent their support behind the event, which is the premier meeting in Asia for medical professionals in the field of cardiology.
CVCT Asia Forum 2014 is the foremost forum dedicated to the discussion of clinical trials in cardiovascular diseases. It provides an excellent platform conducive to peer-to-peer exchanges and enhances scientific productivity.
CVCT meetings are unique as it aims to familiarize practitioners and investigators with the science of clinical trials, from protocol design to the interpretation of results; and are well attended by the scientific, medical and regulatory community from over 30 countries.
Key sessions featured in the Asia forum include the areas of:
- Arrhythmia Trials
- Biomarker Personalised Medicine Trials
- Cardiometabolic Trials
- Heart Failure Drug Trials
- Heart Failure Device Trials
- Interventional Cardiology Trials
- Thrombosis Trials
For registration enquiries, email cvctasia2014.reg@mci-group.com or call +65 6411 6692.
For more information about CVCT Asia Forum 2014, please visit www.cvctasia.com.